133 STAT. 920  PUBLIC LAW 116–22—JUNE 24, 2019  (II) by striking ‘‘and clinical laboratories’’ and  inserting ‘‘, clinical laboratories, and public  environmental health agencies’’;  (iii) by striking ‘‘The network’’ and inserting the  following:  ‘‘(A) IN GENERAL.—The network’’; and  (iv) by adding at the end the following:  ‘‘(B) REVIEW.—Not later than 2 years after the date  of the enactment of the Pandemic and All-Hazards  Preparedness and Advancing Innovation Act of 2019 and  every 6 years thereafter, the Secretary shall conduct a  review of the elements described in subparagraph (A). Such  review shall include a discussion of the addition of any  elements pursuant to clause (v), including elements added  to advancing new technologies, and identify any challenges  in the incorporation of elements under subparagraph (A).  The Secretary shall provide such review to the congres- sional committees of jurisdiction.’’;  Deadline.  Time periods.  (D) in paragraph (5)—  (i) by redesignating subparagraphs (A) through (D)  as clauses (i) through (iv), respectively, and adjusting  the margins accordingly;  (ii) by striking ‘‘In establishing’’ and inserting the  following:  ‘‘(A) IN GENERAL.—In establishing’’;  (iii) by adding at the end the following:  ‘‘(B) PUBLIC MEETING.—  ‘‘(i) IN GENERAL.—Not later than 180 days after  the date of enactment of the Pandemic and All-Hazards  Preparedness and Advancing Innovation Act of 2019,  the Secretary shall convene a public meeting for pur- poses of discussing and providing input on the potential  goals, functions, and uses of the network described  in paragraph (1) and incorporating the elements  described in paragraph (3)(A).  ‘‘(ii) EXPERTS.—The public meeting shall include  representatives of relevant Federal agencies (including  representatives from the Office of the National Coordi- nator for Health Information Technology and the  National Institute of Standards and Technology); State,  local, Tribal, and territorial public health officials;  stakeholders with expertise in biosurveillance and  situational awareness; stakeholders with expertise in  capabilities relevant to biosurveillance and situational  awareness, such as experts in informatics and data  analytics (including experts in prediction, modeling,  or forecasting); and other representatives as the Sec- retary determines appropriate.  ‘‘(iii) TOPICS.—Such public meeting shall include  a discussion of—  ‘‘(I) data elements, including minimal or essen- tial data elements, that are voluntarily provided  for such network, which may include elements  from public health and public and private health  care entities, to the extent practicable;  ‘‘(II) standards and implementation specifica- tions that may improve the collection, analysis,  Deadline. 